NanoSomiX, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the company's first patent covering its groundbreaking proprietary exosome isolation and biomarker detection technology. U.S. Patent No...
Read More »NanoSomix Aims to Launch Neural Exosome Biomarker Tech by Year-End
from GenomeWeb by Doug Macron NEW YORK (GenomeWeb) – With the publication this week of data around its technology for the isolation and analysis of protein biomarkers in neural exosomes, startup NanoSomix is aiming to introduce a blood-based assay for ...
Read More »Technique Using Neuron-derived Exosomes for Brain Insulin Resistance Is Featured at Society for Neuroscience Conference
Technology May Be Useful in Measuring Prognosis and Treatment of Alzheimer’s Disease WASHINGTON, D.C. – A new blood test that detects brain insulin resistance, as an abnormality associated with Alzheimer’s disease, was featured by meeting organizers as a “Hot Topic” ...
Read More »Alzheimer’s Test Detects Disease Decade Ahead of Onset
from Bloomberg News By Megan Scudellari A new blood test for Alzheimer’s appears to detect the disease as many as 10 years before clinical diagnosis is possible — far sooner than other tests in development. The test, described publicly for ...
Read More »Study Says Blood Test for Brain Insulin Resistance Accurately Predicts Alzheimer’s Disease Risk
Technology May Be Useful in Measuring the Prognosis and Treatment of Alzheimer’s Disease October 30, 2014 08:15 AM Eastern Daylight Time ALISO VIEJO, Calif.–(BUSINESS WIRE)–Brain insulin resistance is an abnormality in Alzheimer’s disease that contributes to neural cell damage and ...
Read More »